Recent studies on the genetic basis of ankylosing spondylitis



Recent studies published on the genetic basis of ankylosing spondylitis (AS) reflect novel areas of investigation and extension of recent advances. As HLA-B27 subtypes have been extensively examined in other ethnic groups, novel insights into the relevance of HLA-B27 folding to disease susceptibility have led to questions regarding the influence of HLA-B27 on AS pathogenesis. The recent identification of IL23R, ERAP1, and interleukin-1 (IL1A) region genes in AS pathogenesis has led to a number of replication studies. Other genes with inconsistent AS associations (eg, KIR, TLR4, ANKH, and TNAP) have been further examined with inconsistent results. Potential candidate genes (TIRAP, COL1A6, and MEFV) have been examined with no associations found. Tremendous progress has been made with respect to understanding the genetic basis of AS. The identification of new genes—ARTS1, IL23R, and IL1A—substantiate that susceptibility to AS is also determined by genes outside the MHC.

References and Recommended Reading

  1. 1.
    Brown MA, Laval SH, Brophy S, Calin A: Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis 2000, 59:883–886.PubMedCrossRefGoogle Scholar
  2. 2.
    Brown MA, Kennedy LG, MacGregor AJ, et al.: Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997, 40:1823–1828.PubMedCrossRefGoogle Scholar
  3. 3.
    Pedersen OB, Svendsen AJ, Ejstrup L, et al.: Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation. Scand J Rheumatol 2008, 37:120–126.PubMedCrossRefGoogle Scholar
  4. 4.
    Reveille JD, Maganti RA: Subtypes of HLA B27: History and implications in the pathogenesis of ankylosing spondylitis. In: Molecular Mechanisms of Spondyloarthropathies. Edited by Lopez-Larrea C, Diaz-Pena R. Austin, TX: Landes Bioscience, In press.Google Scholar
  5. 5.
    Galocha B, de Castro JA: Folding of HLA-B27 subtypes is determined by the global effect of polymorphic residues and shows incomplete correspondence to ankylosing spondylitis. Arthritis Rheum 2008, 58:401–412.PubMedCrossRefGoogle Scholar
  6. 6.
    Gunal EK, Sarvan FO, Kamali S, et al.: Low frequency of HLA-B27 in ankylosing spondylitis patients from Turkey. Joint Bone Spine 2008, 75:299–302.PubMedCrossRefGoogle Scholar
  7. 7.
    Lopez-Larrea C, Mijiyawa M, Gonzalez S, et al.: Association of ankylosing spondylitis with HLA-B*1403 in a West African population. Arthritis Rheum 2002, 46:2968–2971.PubMedCrossRefGoogle Scholar
  8. 8.
    Díaz-Peñ R, Blanco-Gelaz MA, Njobvu P, et al.: Influence of HLA-B*5703 and HLA-B*1403 on susceptibility to spondyloarthropathies in the Zambian population. J Rheumatol 2008, 35:2236–2240.CrossRefGoogle Scholar
  9. 9.
    Merino E, Galocha B, Vázquez MN, López de Castro JA: Disparate folding and stability of the ankylosing spondylitis-associated HLA-B*1403 and B*2705 proteins. Arthritis Rheum 2008, 58:3693–3704.PubMedCrossRefGoogle Scholar
  10. 10.
    Ben Radhia K, Ayed-Jendoubi S, Sfar I, et al.: Distribution of HLA-B*27 subtypes in Tunisians and their association with ankylosing spondylitis. Joint Bone Spine 2008, 75:172–175.PubMedCrossRefGoogle Scholar
  11. 11.
    Lee SH, Choi IA, Lee YA, et al.: Human leukocyte antigen-B*2705 is the predominant subtype in the Korean population with ankylosing spondylitis, unlike in other Asians. Rheumatol Int 2008, 29:43–46.PubMedCrossRefGoogle Scholar
  12. 12.
    Nicknam MH, Mahmoudi M, Amirzargar AA, et al.: Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis. Iran J Allergy Asthma Immunol 2008, 7:19–24.PubMedGoogle Scholar
  13. 13.
    van der Linden SM, Valkenburg HA, de Jongh BM, Cats A: The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984, 27:241–249.PubMedCrossRefGoogle Scholar
  14. 14.
    Brown MA, Pile KD, Kennedy LG, et al.: HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996, 55:268–270.PubMedCrossRefGoogle Scholar
  15. 15.
    Wei JC, Tsai WC, Lin HS, et al.: HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients. Rheumatology (Oxford) 2004, 43:839–842.CrossRefGoogle Scholar
  16. 16.
    Jiao YL, Ma CY, Wang LC, et al.: Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease. J Clin Immunol 2008, 28:343–349.PubMedCrossRefGoogle Scholar
  17. 17.
    Lu MC, Yang KL, Tung CH, et al.: Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from Chinese ankylosing spondylitis patients with -308G/A polymorphism in promoter region of tumor necrosis factor: association with distinct A33/B58/Cw10 haplotypes. Rheumatol Int 2008, 29:189–195.PubMedCrossRefGoogle Scholar
  18. 18.
    Brionez TA, Reveille JD: The contribution of genes outside the major histocompatibility complex to susceptibility to ankylosing spondylitis. Curr Opin Rheumatol 2008, 20:384–391.PubMedCrossRefGoogle Scholar
  19. 19.
    Carter KW, Pluzhnikov A, Timms AE, et al.: Combined analysis of three whole genome linkage scans for ankylosing spondylitis. Rheumatology (Oxford) 2007, 46:763–771.CrossRefGoogle Scholar
  20. 20.
    Huang J, Li C, Xu H, Gu J: Novel non-HLA-susceptible regions determined by meta-analysis of four genome-wide scans for ankylosing spondylitis. J Genet 2008, 87:75–81.PubMedCrossRefGoogle Scholar
  21. 21.
    Martin TM, Zhang G, Luo J, et al.: A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum 2005, 52:269–274.PubMedCrossRefGoogle Scholar
  22. 22.
    WTCCC and TASC: Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature Genetics 2007, 39:1329–1337.CrossRefGoogle Scholar
  23. 23.
    Yan J, Parekh VV, Mendez-Fernandez Y, et al.: In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J Exp Med 2006, 203:647–659.PubMedCrossRefGoogle Scholar
  24. 24.
    Maksymowych WP, Inman RD, Gladman DD, et al.: Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis Rheum 2009, 60:1317–1323.PubMedCrossRefGoogle Scholar
  25. 25.
    Tsui FW, Haroon N, Reveille JD, et al.: Association of an ERAP1/ERAP2 haplotype with familial ankylosing spondylitis. Ann Rheum Dis 2009 May 10 (Epub ahead of print).Google Scholar
  26. 26.
    Karaderi T, Harvey D, Farrar C, et al.: Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series. Rheumatology (Oxford) 2009, 48:386–389.CrossRefGoogle Scholar
  27. 27.
    Rahman P, Inman RD, Gladman DD, et al.: Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum 2008, 58:1020–1025.PubMedCrossRefGoogle Scholar
  28. 28.
    Rueda B, Orozco G, Raya E, et al.: The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis 2008, 67:1451–1454.PubMedCrossRefGoogle Scholar
  29. 29.
    Sung IH, Kim TH, Bang SY, et al.: IL-23R polymorphisms in patients with ankylosing spondylitis in Korea. J Rheumatol 2009, 36:1003–1005.PubMedCrossRefGoogle Scholar
  30. 30.
    Sims AM, Timms AE, Bruges-Armas J, et al.: Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis 2008, 67:1305–1309.PubMedCrossRefGoogle Scholar
  31. 31.
    Kim TJ, Kim TH, Lee HJ, et al.: Interleukin 1 polymorphisms in patients with ankylosing spondylitis in Korea. J Rheumatol 2008, 35:1603–1608.PubMedCrossRefGoogle Scholar
  32. 32.
    Beyeler C, Armstrong M, Bird HA, et al.: Relationship between genotype for the cytochrome p450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis. Ann Rheum Dis 1996, 55:66–68.PubMedCrossRefGoogle Scholar
  33. 33.
    Brown MA, Edwards S, Hoyle E, et al.: Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis. Hum Mol Genet 2000, 9:1563–1566.PubMedCrossRefGoogle Scholar
  34. 34.
    Erden G, Acar FS, Inal EE, et al.: Frequency of mutated allele CYP2D6*4 in the Turkish ankylosing spondylitis patients and healthy controls. Rheumatol Int 2009 Feb 26 (Epub ahead of print).Google Scholar
  35. 35.
    Furuichi T, Maeda K, Chou CT, et al.: Association of the MSX2 gene polymorphisms with ankylosing spondylitis in Japanese. J Hum Genet. 2008, 53:419–424.PubMedCrossRefGoogle Scholar
  36. 36.
    Tsui FW, Tsui HW, Cheng EY, et al.: Novel genetic markers in the 5′-flanking region of ANKH are associated with ankylosing spondylitis. Arthritis Rheum 2003, 48:791–797.PubMedCrossRefGoogle Scholar
  37. 37.
    Timms AE, Zhang Y, Bradbury L, et al.: Investigation of the role of ANKH in ankylosing spondylitis. Arthritis Rheum 2003, 48:2898–2902.PubMedCrossRefGoogle Scholar
  38. 38.
    Tsui HW, Inman RD, Reveille JD, Tsui FW: Association of a TNAP haplotype with ankylosing spondylitis. Arthritis Rheum 2007, 56:234–243.PubMedCrossRefGoogle Scholar
  39. 39.
    Cheng N, Cai Q, Fang M, et al.: No significant association between genetic polymorphisms in the TNAP gene and ankylosing spondylitis in the Chinese Han population. Rheumatol Int 2009, 29:305–310.PubMedCrossRefGoogle Scholar
  40. 40.
    Lopez-Larrea C, Blanco-Gelaz MA, Torre-Alonso JC, et al.: Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations. Arthritis Res Ther 2006, 8:R101.PubMedCrossRefGoogle Scholar
  41. 41.
    Díaz-Peña R, Blanco-Gelaz MA, Suárez-Alvarez B, et al.: Activating KIR genes are associated with ankylosing spondylitis in Asian populations. Hum Immunol 2008, 69:437–442.PubMedCrossRefGoogle Scholar
  42. 42.
    Harvey D, Pointon JJ, Sleator C, et al.: Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis. Ann Rheum Dis 2009, 68:595–598.PubMedCrossRefGoogle Scholar
  43. 43.
    van der Paardt M, Crusius JB, de Koning MH, et al.: No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis. Ann Rheum Dis 2005, 64:235–238.PubMedCrossRefGoogle Scholar
  44. 44.
    Adam R, Sturrock RD, Gracie JA: TLR4 mutations (Asp-299Gly and Thr399Ile) are not associated with ankylosing spondylitis. Ann Rheum Dis 2006, 65:1099–1101.PubMedCrossRefGoogle Scholar
  45. 45.
    Snelgrove T, Lim S, Greenwood C, et al.: Association of toll-like receptor 4 variants and ankylosing spondylitis: a case-control study. J Rheumatol 2007, 34:368–370.PubMedGoogle Scholar
  46. 46.
    Pointon JJ, Chapman K, Harvey D, et al.: Toll-like receptor 4 and CD14 polymorphisms in ankylosing spondylitis: evidence of a weak association in Finns. J Rheumatol 2008, 35:1609–1612.PubMedGoogle Scholar
  47. 47.
    Na KS, Kim TH, Rahman P, et al.: Analysis of single nucleotide polymorphisms in Toll-like receptor 4 shows no association with ankylosing spondylitis in a Korean population. Rheumatol Int 2008, 28:627–630.PubMedCrossRefGoogle Scholar
  48. 48.
    Cantaert T, Stone MA, ter Borg M, et al.: A functional polymorphism of TIR-domain-containing adaptor protein is not associated with axial spondyloarthritis. Ann Rheum Dis 2008, 67:720–722.PubMedCrossRefGoogle Scholar
  49. 49.
    Kim TH, Kim TJ, Lee HS, et al.: Single nucleotide polymorphism of COL6A1 in patients with ankylosing spondylitis. J Rheumatol 2008, 35:1849–1852.PubMedCrossRefGoogle Scholar
  50. 50.
    Cinar M, Dinc A, Simsek I, et al.: The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study. Rheumatol Int 2008, 29:37–42.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  1. 1.Division of Rheumatology and Clinical ImmunogeneticsThe University of Texas Health Science Center at HoustonHoustonUSA

Personalised recommendations